Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean 60 4s 1?
Displaying drugs 10701 - 10725 of 12998 in total

Bepranemab

Bepranemab is a recombinant humanized Igg4P monoclonal antibody directed against human Tau.
Investigational
Matched Synonyms: … Immunoglobulin g4 (226-proline), anti-(human tau protein) (human-rattus norvegicus monoclonal ucb0107 .gamma.4- …

Fulacimstat

Fulacimstat is under investigation in clinical trial NCT02452515 (A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction).
Investigational
Matched Iupac: … 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro- ... 1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid …
Matched Categories: … Heterocyclic Compounds, 1-Ring …

6-hydroxy-FAD

Experimental
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[hydroxy({[(2R,3S,4S)-2,3,4 …

Cefatrizine

Experimental
Matched Iupac: … -5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ... (6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(1H-1,2,3-triazol-4-ylsulfanyl)methyl] …

PCI-27483

PCI-27483 has been used in trials studying the treatment of Pancreatic Cancer, Ductal Adrenocarcinoma, and Exocrine Pancreatic Cancer.
Investigational

Beinaglutide

Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).
Investigational
Matched Categories: … Glucagon-like peptide-1 (GLP-1) analogues …

CoA-S-trimethylene-acetyl-tryptamine

Experimental
Matched Name: … CoA-S-trimethylene-acetyl-tryptamine …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[( ... 4-{[2-(1H-indol-3-yl)ethyl]carbamoyl}butyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy …

N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl)

Experimental
Matched Name: … N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl) …
Matched Iupac: … methyl 2-{4'-[(N-{1-[(1H-imidazol-2-yl)methyl]piperidin-4-yl}-1-(4-pentylphenyl)formamido)methyl]-[1,1 ... '-biphenyl]-4-yl}acetate …

(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol

Experimental

Batroxobin

Batroxobin is a defibrinogenating hemostatic agent derived from the venom of a pit viper, Bothrops atrox moojeni. In addition to batroxobin, the venom of Bothrops atrox has a composition of 10.2% neutral carbohydrate. Batroxobin is a serine protease, which cleaves the 16 Arginine - 17 Glycine bond in fibrinogen. The...
Experimental
Matched Description: … The MW of batroxobin is approximately 43,000 g/mol-1, and it contains 231 amino acids. …

4-Bromo-2,5-dimethoxyphenethylamine

Experimental
Illicit
Matched Name: … 4-Bromo-2,5-dimethoxyphenethylamine …
Matched Iupac: … 2-(4-bromo-2,5-dimethoxyphenyl)ethan-1-amine …
Matched Categories: … Adrenergic alpha-1 Receptor Agonists …

4-Hydroxy-3-Methyl Butyl Diphosphate

Experimental
Matched Name: … 4-Hydroxy-3-Methyl Butyl Diphosphate …
Matched Iupac: … ({hydroxy[(3S)-4-hydroxy-3-methylbutoxy]phosphoryl}oxy)phosphonic acid …

4-iodo-acetamido phenylboronic acid

Experimental
Matched Name: … 4-iodo-acetamido phenylboronic acid …

L-2-amino-4-methoxy-cis-but-3-enoic acid

Experimental
Matched Name: … L-2-amino-4-methoxy-cis-but-3-enoic acid …
Matched Iupac: … (2S,3Z)-2-amino-4-methoxybut-3-enoic acid …

4-Methyl-Pyrroline-5-Carboxylic Acid

Experimental
Matched Name: … 4-Methyl-Pyrroline-5-Carboxylic Acid …

(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE

Experimental
Matched Name: … (2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE …
Matched Iupac: … (2R)-2-phenyl-N-(pyridin-4-yl)butanamide …

GT 389-255

Peptimmune’s lead product GT 389-255, is a novel lipase inhibitor and fat binding hydrogel polymer conjugate for the treatment of obesity which has completed single and multiple ascending dose (SAD and MAD) Phase I trials. It is expected to block fat absorption with fewer side effects than currently marketed lipase...
Investigational

Propentofylline

Investigational
Matched Iupac: … 3-methyl-1-(5-oxohexyl)-7-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione …

Clostebol acetate

Experimental
Matched Synonyms: … 4-Chlorotestosterone acetate …
Matched Iupac: … 9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1- …

INM004

INM004, a Neutralizing Equine Anti-Stx Hyperimmune Immunoglobulin F(Ab')2 Fragment, is currently being investigated to treat Shiga-toxin producing bacterial infection relating to the prevention of hemolytic uremic syndrome.
Investigational

12-Hydroxydodecanoic Acid

Experimental

AAV2/8.TBG.hARSB

Investigational

Doxofylline

Doxofylline is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies. In contrast with other xanthine derivatives, doxofylline does...
Experimental
Matched Description: … contrast with other xanthine derivatives, doxofylline does not significantly bind to adenosine alpha-1 …

Imidazole

Experimental
Investigational
Matched Categories: … Heterocyclic Compounds, 1-Ring …

KD3010

KD3010 is a small molecule peroxisome proliferator-activator receptor delta (PPAR Delta) agonist for the treatment of metabolic disorders, including obesity.
Investigational
Matched Iupac: … 4-methylbenzene-1-sulfonic acid; 4-{[(2R,6S)-2,6-dimethyl-4-[4-(trifluoromethoxy)phenyl]piperazin-1-yl …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Displaying drugs 10701 - 10725 of 12998 in total